US Stock MarketDetailed Quotes

AUTL Autolus Therapeutics

Watchlist
  • 2.790
  • -0.010-0.36%
Trading Nov 21 11:53 ET
742.48MMarket Cap-2286P/E (TTM)

Autolus Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Autolus Therapeutics Q3 2024 Earnings Date

Currency：USDNov 12, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
155.00K
0
-155.00K
Miss Est.
-61.82%
-100.00%
-100.00%
EPS
-0.22
-0.31
-0.09
Miss Est.
+16.66%
-19.23%
-43.12%
Analyst Rating
Strong Buy

Nov 20, 2024

Autolus Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 2.979M--
Aug 8, 20192019/Q2-- / 500.000K--
Nov 12, 20242024/Q30.000 / 155.000K--
Aug 8, 20242024/Q20.000 / 62.500K--
May 17, 20242024/Q110.091M / 25.047M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 2.979M--
Aug 8, 20192019/Q2-- / 500.000K--
Nov 12, 20242024/Q30.000 / 155.000K--
Aug 8, 20242024/Q20.000 / 62.500K--
May 17, 20242024/Q110.091M / 25.047M--

Unlock Free Earnings Estimates

Autolus Therapeutics Earnings Reports

  • Autolus Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 13 05:33

  • Autolus Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 9 04:26

  • Autolus Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 18 04:44

  • Autolus Therapeutics | 10-K: FY2023 Annual Report

    Mar 22 10:17

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 20, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data